Robocath joins forces with Stereotaxis

We are particularly proud to share that Robocath is becoming part of Stereotaxis, a major step that brings together two global leaders with a shared ambition : to shape the future of endovascular care.

Beyond the strategic rationale, this moment is first and foremost about people, vision, and leadership. Joining Stereotaxis under David Fischel’s leadership is both inspiring and reassuring. His vision, combined with the strength of the teams, creates a powerful foundation to build a true success story.

What makes this transition even more meaningful is the momentum we’ve built at Robocath. Achieving a First-In-Human procedure with our next-generation robotic platform was not just a milestone — it was the result of bold thinking and deep collaboration across teams.

This new chapter is an opportunity to go further, faster. By combining our complementary technologies and expertise, we are uniquely positioned to deliver fully integrated robotic solutions across electrophysiology, interventional cardiology, and neurointerventions.

Press Release: https://www.robocath.com/wp-content/uploads/2026/04/Stereotaxis-Announces-Definitive-Agreement-to-Acquire-Robocath.pdf